EBS · —

Cosmo N.V. (COPN.SW) Stock

$60.90 +0.00% EBS: COPN.SW

Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo.

Valuation

MetricValue
Price$60.90
Market Cap
P/E Ratio
P/B Ratio
P/S Ratio
EPS (TTM)
52-Week High$129.40
52-Week Low$55.20
Dividend Yield

Financials & Margins

MetricValue
ROE
ROA
ROCE
Gross Margin
Operating Margin
Net Margin
Debt/Equity
Current Ratio

Latest News

Netcompany upgrade revenue guidance for full year 2026 GlobeNewswire · Aug 13, 2026 5 Must-Read Analyst Questions From TransDigm’s Q2 Earnings Call StockStory · Aug 13, 2026 Billionaire Ken Griffin Said an AI System at Citadel Reproduced 8 Weeks of Ph.D.-Level Research in 2 Hours. He Now Believes AI Will Spark a "Golden Age" of Entrepreneurship. Motley Fool · Aug 13, 2026 PLUG Q2 Deep Dive: Margin Gains and Cost Discipline, Guidance Raised StockStory · Aug 13, 2026 BYD (SEHK:1211), What Is The Latest Update Really Telling Investors? Simply Wall St. · Aug 13, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA
FCF Yield
Quick Ratio
Interest Coverage
Return 1Y12.53%
Return 3Y50.25%
Return 5Y-15.90%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AEVS.SWAevis Victoria SA $12.95 -0.38% 43.76 $1.09B 0.00%
BSLN.SWBasilea Pharmaceutica AG $52.60 +2.33% 0.00%
CLTN.SWCOLTENE Holding AG $49.00 -2.78% 0.00%
IDIA.SWIdorsia Ltd $6.73 +3.38% 121.66 $1.78B 0.00%
KURN.SWKuros Biosciences AG $23.00 -0.17% 0.00%

About Cosmo N.V.

Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.

Cosmo N.V. is led by CEO Giovanni di Napoli, employs 325 people, headquartered in Dublin, IE, publicly traded since 2007.

over the past 52 weeks the stock has ranged between $55.20 and $129.40, and currently trades 52.9% below its 52-week high.

Official website: www.cosmopharma.com

Related — Stocks

BNY $152.52 -2.54% CIEN $412.39 +2.14% CBRS $188.61 -5.28% HEI.A AIRCRAFT ENGINES & ENGINE PARTS $216.35 +0.00% LEN.B GENERAL BLDG CONTRACTORS - RESIDENTIAL BLDGS $80.32 +0.00% WSO.B WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES $453.37 +0.00% MKC.V MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS $51.78 +0.00% MOG.B MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $322.00 +0.00% MOG.A MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $307.91 +0.00% UHAL.B SERVICES-AUTO RENTAL & LEASING (NO DRIVERS) $45.71 +0.00% TAP.A MALT BEVERAGES $47.89 +0.00% VSXY $88.68 +0.50%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides